Subcortical grey matter changes in untreated, early stage Parkinson's disease without dementia

Parkinsonism and Related Disorders

Volumn 20, Issue 6, 2014, Pages 622-626

  Lee, Hye Mi ^a   Kwon, Kyum Yil ^a   Kim, Min Jik ^a   Jang, Ji Wan ^a   Suh, Sang il ^a   Koh, Seong Beom ^a   Kim, Ji Hyun ^a  

^a Korea University College of Medicine   (South Korea)

Author keywords

Parkinson's disease; Regional volumetry; Shape analysis; Subcortical grey matter; Voxel based morphometry

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN SIZE; CLINICAL ARTICLE; CONTROLLED STUDY; DEMENTIA; DISEASE DURATION; DISEASE SEVERITY; FEMALE; GRAY MATTER; HIPPOCAMPUS; HUMAN; MALE; NUCLEUS ACCUMBENS; PARKINSON DISEASE; PRIORITY JOURNAL; PUTAMEN; RETROSPECTIVE STUDY; SUBCORTEX; VOLUMETRY; VOXEL BASED MORPHOMETRY; BRAIN; IMAGE PROCESSING; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY;

AGED; BRAIN; FEMALE; GRAY MATTER; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PARKINSON DISEASE;

EID: 84900015444     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2014.03.009     Document Type: Article

References (35)

1. Melzer T.R., Watts R., MacAskill M.R., Pitcher T.L., Livingston L., Keenan R.J., et al. Grey matter atrophy in cognitively impaired Parkinson's disease. J Neurol Neurosurg Psychiatr 2012, 83:188-194.
2. Summerfield C., Junque C., Tolosa E., Salgado-Pineda P., Gomez-Anson B., Marti M.J., et al. Structural brain changes in Parkinson disease with dementia: a voxel-based morphometry study. Arch Neurol 2005, 62:281-285.
3. Lee J.E., Park B., Song S.K., Sohn Y.H., Park H.J., Lee P.H. A comparison of gray and white matter density in patients with Parkinson's disease dementia and dementia with Lewy bodies using voxel-based morphometry. Mov Disord 2010, 25:28-34.
4. Nagano-Saito A., Washimi Y., Arahata Y., Kachi T., Lerch J.P., Evans A.C., et al. Cerebral atrophy and its relation to cognitive impairment in Parkinson disease. Neurology 2005, 64:224-229.
5. Burton E.J., McKeith I.G., Burn D.J., Williams E.D., O'Brien J.T. Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls. Brain 2004, 127:791-800.
6. Price S., Paviour D., Scahill R., Stevens J., Rossor M., Lees A., et al. Voxel-based morphometry detects patterns of atrophy that help differentiate progressive supranuclear palsy and Parkinson's disease. Neuroimage 2004, 23:663-669.
7. Feldmann A., Illes Z., Kosztolanyi P., Illes E., Mike A., Kover F., et al. Morphometric changes of gray matter in Parkinson's disease with depression: a voxel-based morphometry study. Mov Disord 2008, 23:42-46.
8. Tinaz S., Courtney M.G., Stern C.E. Focal cortical and subcortical atrophy in early Parkinson's disease. Mov Disord 2011, 26:436-441.
9. Messina D., Cerasa A., Condino F., Arabia G., Novellino F., Nicoletti G., et al. Patterns of brain atrophy in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy. Parkinsoniam Relat Disord 2011, 17:172-176.
10. Geng D.Y., Li Y.X., Zee C.S. Magnetic resonance imaging-based volumetric analysis of basal ganglia nuclei and substantia nigra in patients with Parkinson's disease. Neurosurgery 2006, 58:256-262.
11. Peran P., Cherubini A., Assogna F., Piras F., Quattrocchi C., Peppe A., et al. Magnetic resonance imaging markers of Parkinson's disease nigrostriatal signature. Brain 2010, 133:3423-3433.
12. Patenaude B., Smith S.M., Kennedy D.N., Jenkinson M.A. Bayesian model of shape and appearance for subcortical brain segmentation. Neuroimage 2011, 56:907-922.
13. Dubois B., Burn D., Goetz C., Aarsland D., Brown R.G., Broe G.A., et al. Diagnostic procedures for Parkinson's disease dementia: recommendations from the movement disorder society task force. Mov Disord 2007, 22:2314-2324.
14. Ashburner J. A fast diffeomorphic image registration algorithm. Neuroimage 2007, 38:95-113.
15. Fischl B., Salat D.H., Busa E., Albert M., Dieterich M., Haselgrove C., et al. Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron 2002, 33:341-355.
16. Bilgic B., Bayram A., Arslan A.B., Hanagasi H., Dursun B., Gurvit H., et al. Differentiating symptomatic Parkin mutations carriers from patients with idiopathic Parkinson's disease: contribution of automated segmentation neuroimaging method. Parkinsoniam Relat Disord 2012, 18:562-566.
17. Zaja-Milatovic S., Milatovic D., Schantz A.M., Zhang J., Montine K.S., Samii A., et al. Dendritic degeneration in neostriatal medium spiny neurons in Parkinson disease. Neurology 2005, 64:545-547.
18. Huot P., Levesque M., Parent A. The fate of striatal dopaminergic neurons in Parkinson's disease and Huntington's chorea. Brain 2007, 130:222-232.
19. Ghaemi M., Hilker R., Rudolf J., Sobesky J., Heiss W.D. Differentiating multiple system atrophy from Parkinson's disease: contribution of striatal and midbrain MRI volumetry and multi-tracer PET imaging. J Neurol Neurosurg Psychiatr 2002, 73:517-523.
20. Kish S.J., Shannak K., Hornykiewicz O. Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications. N Engl J Med 1988, 318:876-880.
21. Nandhagopal R., Kuramoto L., Schulzer M., Mak E., Cragg J., Lee C.S., et al. Longitudinal progression of sporadic Parkinson's disease: a multi-tracer positron emission tomography study. Brain 2009, 132:2970-2979.
22. Morrish P.K., Sawle G.V., Brooks D.J. An [18F]dopa-PET and clinical study of the rate of progression in Parkinson's disease. Brain 1996, 119:585-591.
23. Redgrave P., Rodriguez M., Smith Y., Rodriguez-Oroz M.C., Lehericy S., Bergman H., et al. Goal-directed and habitual control in the basal ganglia: implications for Parkinson's disease. Nat Rev Neurosci 2010, 11:760-772.
24. Remy P., Doder M., Lees A., Turjanski N., Brooks D. Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system. Brain 2005, 128:1314-1322.
25. Weintraub D., Newberg A.B., Cary M.S., Siderowf A.D., Moberg P.J., Kleiner-Fisman G., et al. Striatal dopamine transporter imaging correlates with anxiety and depression symptoms in Parkinson's disease. J Nucl Med 2005, 46:227-232.
26. Dagher A., Robbins T.W. Personality, addiction, dopamine: insights from Parkinson's disease. Neuron 2009, 61:502-510.
27. Steeves T.D., Miyasaki J., Zurowski M., Lang A.E., Pellecchia G., Van Eimeren T., et al. Increased striatal dopamine release in Parkinsonian patients with pathological gambling: a [11C] raclopride PET study. Brain 2009, 132:1376-1385.
28. O'Sullivan S.S., Wu K., Politis M., Lawrence A.D., Evans A.H., Bose S.K., et al. Cue-induced striatal dopamine release in Parkinson's disease-associated impulsive-compulsive behaviours. Brain 2011, 134:969-978.
29. Politis M., Loane C., Wu K., O'Sullivan S.S., Woodhead Z., Kiferle L., et al. Neural response to visual sexual cues in dopamine treatment-linked hypersexuality in Parkinson's disease. Brain 2013, 136:400-411.
30. Camicioli R., Moore M.M., Kinney A., Corbridge E., Glassberg K., Kaye J.A. Parkinson's disease is associated with hippocampal atrophy. Mov Disord 2003, 18:784-790.
31. Bouchard T.P., Malykhin N., Martin W.R., Hanstock C.C., Emery D.J., Fisher N.J., et al. Age and dementia-associated atrophy predominates in the hippocampal head and amygdala in Parkinson's disease. Neurobiol Aging 2008, 29:1027-1039.
32. Tam C.W., Burton E.J., McKeith I.G., Burn D.J., O'Brien J.T. Temporal lobe atrophy on MRI in Parkinson disease with dementia: a comparison with Alzheimer disease and dementia with Lewy bodies. Neurology 2005, 64:861-865.
33. Apostolova L.G., Beyer M., Green A.E., Hwang K.S., Morra J.H., Chou Y.Y., et al. Hippocampal, caudate, and ventricular changes in Parkinson's disease with and without dementia. Mov Disord 2010, 25:687-695.
34. Carlesimo G.A., Piras F., Assogna F., Pontieri F.E., Caltagirone C., Spalletta G. Hippocampal abnormalities and memory deficits in Parkinson disease: a multimodal imaging study. Neurology 2012, 78:1939-1945.
35. Bruck A., Kurki T., Kaasinen V., Vahlberg T., Rinne J.O. Hippocampal and prefrontal atrophy in patients with early non-demented Parkinson's disease is related to cognitive impairment. J Neurol Neurosurg Psychiatr 2004, 75:1467-1469.